Abbonarsi

Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features - 21/08/20

Doi : 10.1016/j.diii.2020.03.002 
S. Park a, L.C. Chu a, R.H. Hruban b, c, B. Vogelstein c, d, e, K.W. Kinzler c, d, A.L. Yuille f, g, D.F. Fouladi a, S. Shayesteh a, S. Ghandili a, C.L. Wolfgang h, R. Burkhart h, J. He h, E.K. Fishman a, S. Kawamoto a, ⁎
a The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, JHOC 3140E, 601N. Caroline Street, 21287 Baltimore, USA 
b Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, School of Medicine, Johns Hopkins University, 21287 Baltimore, USA 
c Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, 21287 Baltimore, USA 
d Johns Hopkins University, School of Medicine, Ludwig Center for Cancer Genetics and Therapeutics, 21231 Baltimore, USA 
e Howard Hughes Medical Institute Investigator, Johns Hopkins University School of Medicine, 21231 Baltimore, USA 
f Johns Hopkins University, School of Arts and Sciences, Department of Computer Science, 21218 Baltimore, USA 
g Johns Hopkins University, School of Arts and Sciences, Department of Cognitive Science, 21218 Baltimore, USA 
h Johns Hopkins University, School of Medicine, Department of Surgery, 21287 Baltimore, USA 

⁎Corresponding author at: The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, JHOC 3140E, 601N. Caroline Street, 21287 Baltimore, USA.The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins UniversityJHOC 3140E, 601N. Caroline StreetBaltimore21287USA

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

•
CT radiomics differentiates AIP from PDAC with 89.7% sensitivity and 100% specificity.
•
Thin slice CT radiomics better differentiates AIP from PDAC than thick slice CT radiomics.
•
Venous phase CT radiomics better differentiates AIP from PDAC than arterial phase radiomics.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Purpose

The purpose of this study was to determine whether computed tomography (CT)-based machine learning of radiomics features could help distinguish autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC).

Materials and Methods

Eighty-nine patients with AIP (65 men, 24 women; mean age, 59.7±13.9 [SD] years; range: 21–83 years) and 93 patients with PDAC (68 men, 25 women; mean age, 60.1±12.3 [SD] years; range: 36–86 years) were retrospectively included. All patients had dedicated dual-phase pancreatic protocol CT between 2004 and 2018. Thin-slice images (0.75/0.5mm thickness/increment) were compared with thick-slices images (3 or 5mm thickness/increment). Pancreatic regions involved by PDAC or AIP (areas of enlargement, altered enhancement, effacement of pancreatic duct) as well as uninvolved parenchyma were segmented as three-dimensional volumes. Four hundred and thirty-one radiomics features were extracted and a random forest was used to distinguish AIP from PDAC. CT data of 60 AIP and 60 PDAC patients were used for training and those of 29 AIP and 33 PDAC independent patients were used for testing.

Results

The pancreas was diffusely involved in 37 (37/89; 41.6%) patients with AIP and not diffusely in 52 (52/89; 58.4%) patients. Using machine learning, 95.2% (59/62; 95% confidence interval [CI]: 89.8–100%), 83.9% (52:67; 95% CI: 74.7–93.0%) and 77.4% (48/62; 95% CI: 67.0–87.8%) of the 62 test patients were correctly classified as either having PDAC or AIP with thin-slice venous phase, thin-slice arterial phase, and thick-slice venous phase CT, respectively. Three of the 29 patients with AIP (3/29; 10.3%) were incorrectly classified as having PDAC but all 33 patients with PDAC (33/33; 100%) were correctly classified with thin-slice venous phase with 89.7% sensitivity (26/29; 95% CI: 78.6–100%) and 100% specificity (33/33; 95% CI: 93–100%) for the diagnosis of AIP, 95.2% accuracy (59/62; 95% CI: 89.8–100%) and area under the curve of 0.975 (95% CI: 0.936–1.0).

Conclusions

Radiomic features help differentiate AIP from PDAC with an overall accuracy of 95.2%.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Radiomics, Texture analysis, Autoimmune pancreatitis, Pancreatic ductal carcinoma, Computed tomography (CT)

Abbreviations : AIP, AUC, CI, CT, DW-MRI, FDG18, HGLRE, HU, IDMN, IDN, IgG4, IMC, IPMN, LGLRE, LHH, LHL, LLH, LLL, LRHGLE, LRLGLE, MDCT, MRI, PDAC, PET, PET-CT, RMS, ROC, SD, 3D, SRHGLE, SRLGLE


Mappa


© 2020  Société française de radiologie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 101 - N° 9

P. 555-564 - settembre 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy
  • A.A.K. Abdel Razek, L.G. El-Serougy, G.A. Saleh, W. Shabana, R. Abd El-Wahab
| Articolo seguente Articolo seguente
  • Computed tomography features of acinar cell carcinoma of the pancreas
  • M. Barat, A. Dohan, S. Gaujoux, C. Hoeffel, D. Jornet, A. Oudjit, R. Coriat, M. Barret, B. Terris, P. Soyer

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.